Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 18 | $8,270,030 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 12 Jul 2024 17:46 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 10 Jul 2024 | Sale | 12,923 | 22.4869 | 290,598 | D |
| 26 Jun 2024 17:07 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 24 Jun 2024 | Sale | 12,930 | 23.1022 | 298,711 | D |
| 12 Feb 2024 20:22 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 08 Feb 2024 | Sale | 92,001 | 27.1282 | 2,495,822 | D |
| 25 Jan 2024 16:59 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 23 Jan 2024 | Sale | 5,696 | 18.4079 | 104,851 | D |
| 08 Jan 2024 16:19 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 05 Jan 2024 | Sale | 133 | 20.105 | 2,674 | D |
| 08 Jan 2024 16:19 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 04 Jan 2024 | Sale | 40,732 | 20.3084 | 827,202 | D |
| 08 Jan 2024 16:19 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 05 Jan 2024 | Sale | 28,104 | 19.5632 | 549,804 | D |
| 08 Jan 2024 16:19 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 18 Dec 2023 | Sale | 4,702 | 18.129 | 85,243 | D |
| 08 Jan 2024 16:19 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 15 Dec 2023 | Sale | 28,632 | 17.2685 | 494,432 | D |
| 23 Feb 2023 19:56 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 22 Feb 2023 | Sale | 16,449 | 20.224 | 332,665 | D |
| 23 Feb 2023 19:56 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 21 Feb 2023 | Sale | 907 | 21.4897 | 19,491 | D |
| 23 Feb 2023 19:56 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 21 Feb 2023 | Sale | 17,090 | 20.9314 | 357,718 | D |
| 23 Jan 2023 19:57 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 20 Jan 2023 | Sale | 8,625 | 20.1886 | 174,127 | D |
| 23 Jan 2023 19:57 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 19 Jan 2023 | Sale | 10,899 | 20.0337 | 218,347 | D |
| 19 Dec 2022 17:56 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer, 10% | 16 Dec 2022 | Sale | 26,349 | 23.3863 | 616,206 | D |
| 19 Dec 2022 17:56 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer, 10% | 16 Dec 2022 | Sale | 27,595 | 22.6625 | 625,372 | D |
| 19 Dec 2022 17:56 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer, 10% | 15 Dec 2022 | Sale | 1,500 | 24.1327 | 36,199 | D |
| 19 Dec 2022 17:56 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer, 10% | 15 Dec 2022 | Sale | 31,433 | 23.5602 | 740,568 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)